GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a prominent focus in medical studies, largely due to its impressive impact on managing diseases such as type 2 diabetes and excess body fat. Ongoing trials have revealed that beyond glucose control, GLP-1 drugs offer promise for cardiovascular well-being and even … Read More